NeuroPace, Inc. (NPCE)

NASDAQ: NPCE · IEX Real-Time Price · USD
13.20
-0.43 (-3.15%)
Mar 28, 2024, 4:30 PM EDT - Market closed

Company Description

NeuroPace, Inc. operates as a medical device company in the United States.

The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy.

It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.

Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.

The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures.

NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

NeuroPace, Inc.
NeuroPace logo
Country United States
Founded 1997
IPO Date Apr 22, 2021
Industry Medical Devices
Sector Healthcare
Employees 171
CEO Joel D. Becker

Contact Details

Address:
455 N. Bernardo Avenue
Mountain View, California 94043
United States
Phone (650) 237-2700
Website neuropace.com

Stock Details

Ticker Symbol NPCE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001528287
CUSIP Number 641288105
ISIN Number US6412881053
Employer ID 22-3550230
SIC Code 3841

Key Executives

Name Position
Dr. Martha J. Morrell Chief Medical Officer
Joel D. Becker Chief Executive Officer, President and Director
Rebecca L. Kuhn Chief Financial Officer, Vice President of Finance and Administration and Assistant Secretary
Kelley Nicholas Vice President of Sales
Irene Thomas Vice President of Human Resources

Latest SEC Filings

Date Type Title
Mar 15, 2024 144 Filing
Mar 5, 2024 S-8 Securities to be offered to employees in employee benefit plans
Mar 5, 2024 10-K Annual Report
Mar 5, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 7, 2024 8-K Current Report
Feb 2, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals